Author

Piotr Kobialka

Goethe University FrankfurtORCID 0000-0003-4765-168XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

Amparo Acker‐PalmeriD· 1 shared Ana Angulo‐UrarteiD· 1 shared Anne SchänzeriD· 1 shared Bettina C. KirchmaieriD· 1 shared Blanca Peguera· 1 shared C. Milla· 1 shared Carlota RoviraiD· 1 shared Cecília Llaó-CidiD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Amparo Acker‐PalmerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceNature CommunicationsPeer-reviewedNov 28, 2024

Vascular FLRT2 regulates venous-mediated angiogenic expansion and CNS barriergenesis

Cecília Llaó-Cid, Blanca Peguera, Piotr Kobialka…·Amparo Acker‐Palmer

This study identifies FLRT2 as a critical regulator of venous-mediated angiogenesis and blood-brain barrier formation in the developing mouse CNS.

10 citations

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJul 16, 2021

Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease

Piotr Kobialka, Helena Sabata, Odena Vilalta…·Mariona Graupera

The paper develops a preclinical model of PI3K-driven vascular malformations and shows that low-dose AKT inhibitor miransertib prevents and regresses these malformations in mice and human endothelial cells.

5 citations

mouseexperimental assay

𝕏 PostBluesky